Close Menu

This article has been updated to include information from Foundation Medicine's earnings call.

NEW YORK (GenomeWeb) – Foundation Medicine reported a 70 percent increase in fourth quarter revenues after the close of market Wednesday, driven by both its clinical testing and biopharma business. The results are in line with the company's pre-announcement of its earnings in January.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 


As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.